Salarius Pharmaceuticals Inc
NASDAQ:SLRX
Salarius Pharmaceuticals Inc Stock, NASDAQ:SLRX
2450 Holcombe Boulevard, Suite X, Houston, Texas 77021
United States of America
Phone: +1.832.834.6992
Number of Employees: 12
Description
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.